# A Single Arm Trial Evaluating the BARD Lutonix Drug-Coated Balloon (LTX DCB) for Treatment of Femoropopliteal Arteries

Study · id `cardio:ct-nct02720003` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02720003](<https://clinicaltrials.gov/study/NCT02720003>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02720003

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 148 participants.

## Technical summary

Registry record NCT02720003. Allocation not applicable; no masking; primary purpose treatment. Start 2016-03 (registry gives no type); primary completion 2018-10 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 148 participants (enrolled count; ClinicalTrials.gov record NCT02720003, source copy `cardio:ctgov-nct02720003-2021-01-20`, retrieved 2026-10-31)
- Start date: 2016-03 (registry gives no type) (ClinicalTrials.gov record NCT02720003, source copy `cardio:ctgov-nct02720003-2021-01-20`, retrieved 2026-10-31)
- Primary completion: 2018-10 (actual) (ClinicalTrials.gov record NCT02720003, source copy `cardio:ctgov-nct02720003-2021-01-20`, retrieved 2026-10-31)
- Completion: 2020-08 (actual) (ClinicalTrials.gov record NCT02720003, source copy `cardio:ctgov-nct02720003-2021-01-20`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT02720003, source copy `cardio:ctgov-nct02720003-2021-01-20`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02720003-2021-01-20`, retrieved 2026-10-31)

## The registry's words

- Brief title: A Single Arm Trial Evaluating the BARD Lutonix Drug-Coated Balloon (LTX DCB) for Treatment of Femoropopliteal Arteries
- Condition: Femoral Artery Stenosis
- Condition: Femoral Artery Occlusion
- Condition: Stenosis of Popliteal Arteries
- Condition: Occlusion of Popliteal Arteries
- Intervention (Device): LTX DCB
- Lead sponsor: C. R. Bard
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry lists this organization as the lead sponsor: C. R. Bard (`cardio:org-c-r-bard`)

## Provenance

Content hash: 47a6c92a601c5a418d34aa9f3b9b551c4942fda2a00dbf7398e980bf0f204c00
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
